While our nephrology department has been using Cystatin C in addition to sCr, it has not been implemented in our ICU due to its limitations in critically ill patients, such as being influenced by age, gender, race, diabetes, steroid treatments, thyroid dysfunction, and inflammation [34,35,36,37]. The gene discussed is CST3; the disease is diabetes mellitus.